Drug Shortage Report for DAPTOMYCIN FOR INJECTION
| Report ID | 163231 |
| Drug Identification Number | 02490838 |
| Brand name | DAPTOMYCIN FOR INJECTION |
| Common or Proper name | DAPTOMYCIN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | DAPTOMYCIN |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | LYVI |
| ATC code | J01XX |
| ATC description | OTHER ANTIBACTERIALS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-22 |
| Estimated end date | 2022-07-08 |
| Actual end date | 2022-07-06 |
| Shortage status | Resolved |
| Updated date | 2022-07-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-07-07 | English | Compare |
| v7 | 2022-07-06 | French | Compare |
| v6 | 2022-07-06 | English | Compare |
| v5 | 2022-06-29 | French | Compare |
| v4 | 2022-06-29 | English | Compare |
| v3 | 2022-06-23 | English | Compare |
| v2 | 2022-06-22 | French | Compare |
| v1 | 2022-06-22 | English | Compare |
Showing 1 to 8 of 8